A comprehensive analysis of Theranos's rise and spectacular fall, examining how Elizabeth Holmes built a $9 billion startup on unproven technology and deception. The episode explores the company's flawed blood-testing technology, the culture of secrecy that enabled fraud, and the crucial role of investigative journalism in exposing the truth. We'll dissect the key warning signs that investors and board members missed, and examine how the desire for revolutionary healthcare innovation clouded rational judgment.